Our re-programmed B-ALL cells confirmed that A-1155463, a BCL-XL inhibitor from AbbVie, also induces specific apoptosis of BCL-XL-expressing cells and to a lesser extent has potency in our BCL-Wre-programmed B-ALL cells. The gene discussed is BCL2L1; the disease is acute lymphoblastic leukemia.